New research published Sept 29, 2016, in JAMA Oncology shows the HPV vaccine is efficacious in reducing cervical pre-cancers among young women throughout a population. The New Mexico HPV Pap Registry was the data source used in the study. The researchers found that among women who were 15 to 19 years old at the time of a diagnostic cervical biopsy, the incidence rate of cervical abnormalities decreased between 2007 and 2014.
Renowned UAB HPV expert, Warner Huh, says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.
A research paper published in The Lancet Oncology showed that a single dose of the human papillomavirus vaccine Cervarix(r) may prevent HPV-related cervical cancer.
A study published on bmj.com reveals that women with pre-cancerous cervical conditions can still benefit from a significantly reduced risk of reoccurring disease after receiving the HPV vaccine. The researchers examined data of 1,35...
Those who got the vaccine were less likely to have potentially cancerous cells The post HPV vaccination reduces cervical abnormalities in young women: study appeared first on Macleans.ca.